Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

44.76
-2.3800-5.05%
Post-market: 45.060.3000+0.67%19:31 EDT
Volume:529.64K
Turnover:23.98M
Market Cap:1.88B
PE:-16.47
High:47.32
Open:47.11
Low:44.60
Close:47.14
Loading ...
Feb 02, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 18, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2023

Major Issues Report

Form 8-K - Current report
Dec 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2023

Correspondence

Form CORRESP - Correspondence
Nov 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2023

Major Issues Report

Form 8-K - Current report